OSE Pharma (France) Top Management
OSE Stock | EUR 7.80 0.41 4.99% |
OSE Pharma employs about 60 people. The company is managed by 10 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 6.0 employees per reported executive. Analysis of OSE Pharma's management performance can provide insight into the company performance.
Brangre Vasseur Insider Chief ImmunoOncology |
Alain MD Insider Medical Director |
OSE |
OSE Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.0528) % which means that it has lost $0.0528 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1482) %, meaning that it generated substantial loss on money invested by shareholders. OSE Pharma's management efficiency ratios could be used to measure how well OSE Pharma manages its routine affairs as well as how well it operates its assets and liabilities.OSE Pharma Workforce Comparison
OSE Pharma SA is regarded third in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 475. OSE Pharma retains roughly 60.0 in number of employees claiming about 13% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.22) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.25. OSE Pharma SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. OSE Pharma SA Price Series Summation is a cross summation of OSE Pharma price series and its benchmark/peer.
OSE Pharma Notable Stakeholders
An OSE Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OSE Pharma often face trade-offs trying to please all of them. OSE Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OSE Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Nicolas Poirier | Scientific Director | Profile | |
Brangre Vasseur | Chief ImmunoOncology | Profile | |
Alain MD | Medical Director | Profile | |
Silvia MD | Head Devel | Profile | |
AnneLaure AutretCornet | Chief Financial and Administrative Officer | Profile | |
JeanPascal PharmD | Chief Person | Profile | |
Dominique MD | Chairman Founder | Profile | |
Alexis Peyroles | Consultant | Profile | |
Julien Perrier | Chief Commercial Officer | Profile | |
Linda MSc | Chief Officer | Profile |
About OSE Pharma Management Performance
The success or failure of an entity such as OSE Pharma SA often depends on how effective the management is. OSE Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OSE management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OSE management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people.
Please note, the presentation of OSE Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OSE Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of OSE Pharma's management manipulating its earnings.
OSE Pharma Workforce Analysis
Traditionally, organizations such as OSE Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OSE Pharma within its industry.OSE Pharma Manpower Efficiency
Return on OSE Pharma Manpower
Revenue Per Employee | 438.4K | |
Revenue Per Executive | 2.6M | |
Net Loss Per Employee | 280.8K | |
Net Loss Per Executive | 1.7M | |
Working Capital Per Employee | 366.7K | |
Working Capital Per Executive | 2.2M |
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets |